TipRanks on MSN
Bluejay Diagnostics scales IL-6 antibody production capacity
An update from Bluejay Diagnostics ( ($BJDX) ) is now available. On December 29, 2025, Bluejay Diagnostics announced it had completed ...
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”) announced that it has completed commercial-scale production of both polyclonal and monoclonal antibodies targeting interleukin-6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback